2016 Q2 Form 10-Q Financial Statement
#000114420416127865 Filed on October 12, 2016
Income Statement
Concept | 2016 Q2 | 2015 Q2 |
---|---|---|
Revenue | $2.936M | $2.936M |
YoY Change | 0.0% | 16.79% |
Cost Of Revenue | $2.120M | $2.050M |
YoY Change | 3.41% | 7.89% |
Gross Profit | $1.063M | $882.4K |
YoY Change | 20.46% | 44.31% |
Gross Profit Margin | 36.2% | 30.05% |
Selling, General & Admin | $1.114M | $1.164M |
YoY Change | -4.3% | -2.0% |
% of Gross Profit | 104.77% | 131.88% |
Research & Development | $137.6K | $200.3K |
YoY Change | -31.29% | 23.67% |
% of Gross Profit | 12.95% | 22.7% |
Depreciation & Amortization | $7.874K | $9.385K |
YoY Change | -16.1% | -20.04% |
% of Gross Profit | 0.74% | 1.06% |
Operating Expenses | $1.251M | $1.364M |
YoY Change | -8.26% | 1.08% |
Operating Profit | -$188.4K | -$481.7K |
YoY Change | -60.89% | -34.73% |
Interest Expense | $4.236K | -$300.0K |
YoY Change | -101.41% | |
% of Operating Profit | ||
Other Income/Expense, Net | -$4.236K | -$8.282K |
YoY Change | -48.85% | |
Pretax Income | -$390.0K | -$777.1K |
YoY Change | -49.81% | 4.61% |
Income Tax | $0.00 | |
% Of Pretax Income | ||
Net Earnings | -$777.1K | -$777.1K |
YoY Change | 0.0% | 4.61% |
Net Earnings / Revenue | -26.46% | -26.46% |
Basic Earnings Per Share | -$0.34 | |
Diluted Earnings Per Share | -$168.8K | -$0.34 |
COMMON SHARES | ||
Basic Shares Outstanding | 2.313M shares | |
Diluted Shares Outstanding | 2.313M shares |
Balance Sheet
Concept | 2016 Q2 | 2015 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $180.0K | $250.0K |
YoY Change | -28.0% | -91.55% |
Cash & Equivalents | $175.8K | $253.4K |
Short-Term Investments | ||
Other Short-Term Assets | $600.0K | $480.0K |
YoY Change | 25.0% | 37.14% |
Inventory | $4.510M | $4.680M |
Prepaid Expenses | ||
Receivables | $340.0K | $930.0K |
Other Receivables | $1.730M | $1.330M |
Total Short-Term Assets | $7.350M | $7.670M |
YoY Change | -4.17% | -9.12% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $60.00K | $100.0K |
YoY Change | -40.0% | -26.25% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $11.40M | $12.56M |
YoY Change | -9.25% | -11.07% |
Other Assets | $10.00K | $30.00K |
YoY Change | -66.67% | -21.33% |
Total Long-Term Assets | $11.53M | $12.76M |
YoY Change | -9.62% | -11.25% |
TOTAL ASSETS | ||
Total Short-Term Assets | $7.350M | $7.670M |
Total Long-Term Assets | $11.53M | $12.76M |
Total Assets | $18.88M | $20.43M |
YoY Change | -7.57% | -10.47% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $2.950M | $1.940M |
YoY Change | 52.06% | 172.39% |
Accrued Expenses | $110.0K | $170.0K |
YoY Change | -35.29% | -22.73% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $430.0K |
YoY Change | -100.0% | |
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $3.070M | $2.540M |
YoY Change | 20.87% | 154.0% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | -100.0% | |
Other Long-Term Liabilities | $0.00 | $0.00 |
YoY Change | ||
Total Long-Term Liabilities | $0.00 | $0.00 |
YoY Change | -100.0% | |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $3.070M | $2.540M |
Total Long-Term Liabilities | $0.00 | $0.00 |
Total Liabilities | $3.070M | $2.540M |
YoY Change | 20.87% | 146.6% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | ||
YoY Change | ||
Common Stock | $12.91M | |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $15.82M | $17.89M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $18.88M | $20.43M |
YoY Change | -7.59% | -10.43% |
Cashflow Statement
Concept | 2016 Q2 | 2015 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$777.1K | -$777.1K |
YoY Change | 0.0% | 4.61% |
Depreciation, Depletion And Amortization | $7.874K | $9.385K |
YoY Change | -16.1% | -20.04% |
Cash From Operating Activities | $290.0K | -$854.7K |
YoY Change | -133.93% | -194.29% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$160.0K | |
YoY Change | ||
Cash From Investing Activities | -$160.0K | $0.00 |
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -310.0K | $426.7K |
YoY Change | -172.65% | |
NET CHANGE | ||
Cash From Operating Activities | 290.0K | -$854.7K |
Cash From Investing Activities | -160.0K | $0.00 |
Cash From Financing Activities | -310.0K | $426.7K |
Net Change In Cash | -180.0K | -$428.0K |
YoY Change | -57.94% | -147.21% |
FREE CASH FLOW | ||
Cash From Operating Activities | $290.0K | -$854.7K |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2015Q2 | us-gaap |
Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
|
11740633 | USD |
CY2015Q2 | us-gaap |
Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
|
-784927 | USD |
CY2016Q2 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
0 | USD |
CY2016Q1 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
313891 | USD |
CY2016Q2 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
3178607 | USD |
CY2015Q2 | uuu |
Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
|
1911257 | USD |
CY2016Q2 | uuu |
Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
|
2043027 | USD |
CY2015Q2 | uuu |
Cost Of Goods Sold Other
CostOfGoodsSoldOther
|
142806 | USD |
CY2016Q2 | uuu |
Cost Of Goods Sold Other
CostOfGoodsSoldOther
|
72586 | USD |
CY2015Q2 | us-gaap |
Gross Profit
GrossProfit
|
882427 | USD |
CY2016Q2 | us-gaap |
Gross Profit
GrossProfit
|
1062994 | USD |
CY2015Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-777077 | USD |
CY2016Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-389679 | USD |
CY2016Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-4236 | USD |
CY2015Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-8282 | USD |
CY2016Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.17 | |
CY2015Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.34 | |
CY2016Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2312887 | shares |
CY2015Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
0 | USD |
CY2016Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-166303 | USD |
CY2015Q2 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-93515 | USD |
CY2016Q2 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
-16580 | USD |
CY2015Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-93515 | USD |
CY2016Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-182883 | USD |
CY2015Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-870592 | USD |
CY2016Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-572562 | USD |
CY2015Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
9385 | USD |
CY2016Q2 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7874 | USD |
CY2015Q2 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2015Q2 | uuu |
Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
|
470055 | USD |
CY2016Q2 | uuu |
Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
|
137066 | USD |
CY2015Q2 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
964984 | USD |
CY2016Q2 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1260118 | USD |
CY2015Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-854703 | USD |
CY2016Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
288221 | USD |
CY2015Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
631906 | USD |
CY2016Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-161305 | USD |
CY2015Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
426732 | USD |
CY2016Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-313891 | USD |
CY2015Q2 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
203935 | USD |
CY2015Q2 | us-gaap |
Interest Paid
InterestPaid
|
9785 | USD |
CY2016Q2 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-186975 | USD |
CY2015Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
49427 | USD |
CY2015Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
253362 | USD |
CY2016Q2 | us-gaap |
Interest Paid
InterestPaid
|
4236 | USD |
CY2016Q2 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2015Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
869073 | USD |
CY2015Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
57000 | USD |
CY2016Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
650112 | USD |
CY2016Q2 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
-313891 | USD |
CY2015Q2 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
426732 | USD |
CY2016Q2 | dei |
Document Type
DocumentType
|
10-Q | |
CY2016Q2 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2016Q2 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2016-06-30 | |
CY2016Q2 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2017 | |
CY2016Q2 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2016Q2 | dei |
Entity Registrant Name
EntityRegistrantName
|
UNIVERSAL SECURITY INSTRUMENTS INC | |
CY2016Q2 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000102109 | |
CY2016Q2 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--03-31 | |
CY2016Q2 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
CY2016Q2 | dei |
Trading Symbol
TradingSymbol
|
UUU | |
CY2016Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
2312887 | shares |
CY2016Q2 | us-gaap |
Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
|
401845 | USD |
CY2016Q1 | us-gaap |
Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
|
139985 | USD |
CY2016Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2016Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2016Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
20000000 | shares |
CY2016Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
20000000 | shares |
CY2016Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2312887 | shares |
CY2016Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2312887 | shares |
CY2016Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2312887 | shares |
CY2016Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2312887 | shares |
CY2016Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
57000 | USD |
CY2016Q1 | uuu |
Working Capital
WorkingCapital
|
4463601 | USD |
CY2016Q2 | us-gaap |
Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
|
5589468 | USD |
CY2015Q2 | us-gaap |
Equity Method Investment Summarized Financial Information Liabilities
EquityMethodInvestmentSummarizedFinancialInformationLiabilities
|
6024586 | USD |
CY2016Q2 | us-gaap |
Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
|
5115432 | USD |
CY2015Q2 | us-gaap |
Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
|
6024586 | USD |
CY2016Q2 | us-gaap |
Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
|
28582355 | USD |
CY2015Q2 | us-gaap |
Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
|
31066085 | USD |
CY2015Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
200303 | USD |
CY2015Q2 | us-gaap |
Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
|
366307 | USD |
CY2015Q2 | us-gaap |
Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
|
4612505 | USD |
CY2016Q2 | us-gaap |
Line Of Credit
LineOfCredit
|
0 | USD |
CY2016Q2 | uuu |
Increase Decrease In Funds Held By Factor
IncreaseDecreaseInFundsHeldByFactor
|
-161305 | USD |
CY2015Q2 | uuu |
Increase Decrease In Funds Held By Factor
IncreaseDecreaseInFundsHeldByFactor
|
631906 | USD |
CY2016Q2 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">Basis of Presentation</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The condensed consolidated financial statements include the accounts of Universal Security Instruments, Inc. (USI or the Company) and its majority owned subsidiary. Except for the condensed consolidated balance sheet as of March 31, 2016, which was derived from audited financial statements, the accompanying condensed consolidated financial statements are unaudited. Significant inter-company accounts and transactions have been eliminated in consolidation. In the opinion of the Company’s management, the interim condensed consolidated financial statements include all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (US-GAAP) have been condensed or omitted. The interim condensed consolidated financial statements should be read in conjunction with the Company’s March 31, 2016 audited financial statements filed with the Securities and Exchange Commission (SEC) on Form 10-K filed on September 28, 2016. The interim operating results are not necessarily indicative of the operating results for the full fiscal year.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2016Q2 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
2600000 | USD |
CY2015Q1 | us-gaap |
Line Of Credit Facility Borrowing Capacity Description
LineOfCreditFacilityBorrowingCapacityDescription
|
The Agreement for the assignment of accounts receivable expires on January 6, 2018 and provides for continuation of the program on successive two year periods until terminated by one of the parties to the Agreement. In accordance with the provisions of the Agreement, the Company may take advances equal to eighty percent (80%) of the uncollected non-recourse factored trade accounts receivable balance less applicable factoring commissions and may borrow up to fifty percent (50%) of eligible inventories subject to a borrowing limitation on inventory of $1,000,000. | |
CY2015Q1 | us-gaap |
Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
|
bears interest at the prime commercial rate of interest, as published, plus two percent (Effective rate 5.50% at June 30, 2016). | |
CY2016Q2 | us-gaap |
Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
|
2485000 | USD |
CY2015Q1 | uuu |
Accounts Receivables Factoring Agreement Expiration Date
AccountsReceivablesFactoringAgreementExpirationDate
|
2018-01-06 | |
CY2015Q1 | uuu |
Accounts Receivables Factoring Agreement Term
AccountsReceivablesFactoringAgreementTerm
|
P2Y | |
CY2016Q2 | uuu |
Increase Decrease In Working Capital
IncreaseDecreaseInWorkingCapital
|
184719 | USD |
CY2016Q2 | uuu |
Working Capital
WorkingCapital
|
4278882 | USD |
CY2016Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1113720 | USD |
CY2015Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1163786 | USD |
CY2016Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
137631 | USD |
CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2137792 | USD |
CY2015 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3704985 | USD |